Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Clinical trial NCT01135914 · COMPLETED
Trial details
- NCT number
- NCT01135914
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2013-03-01
- Enrollment
- 241
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.